Ursodeoxycholic acid (UDCA) for the treatment of amoxycillin-clavulanate potassium (Augmentin®)-induced intra-hepatic cholestasis

Authors:
  • PXPanagiotis Xiarchos
    Panagiotis Xiarchos
  • FPFrida Patakiouta
    Frida Patakiouta
  • KCKiriakos Christodoulou
    Kiriakos Christodoulou
  • IPIoannis Pilpilidis
    Ioannis Pilpilidis
  • NENikos Eugenidis
    Nikos Eugenidis

Abstract
This report describes two patients who developed jaundice within two weeks of receiving an amoxycillin-clavulanate potassium combination. Causes of jaundice, other than drug administration, were excluded. The patients' jaundice and clinical symptoms did not respond to stopping the drug. Ursodeoxycholic acid (750 mg/day) led to a prompt and sustained improvement in their hyperbilirubinaemia and symptoms such as pruritus and fatigue. These cases suggest that ursodeoxycholic acid may be an effective treatment for drug-associated cholestasis.
Keywords